Navigation Links
Patient Safety Technologies Reports First Quarter 2011 Results
Date:5/23/2011

odate an upgrade to their IT system and 3) the effect of certain inventory management practices of our exclusive distributor during the first quarter of 2011.

Reported gross profit was $0.9 million in the first quarter of 2011 as compared to $1.3 million during the same period in 2010.  The primary factor for the decrease in reported gross profit was the lower revenue recognized from the inventory stocking order in the first quarter of 2011 as compared to the same period in 2010.  Reported gross margins were 47% and 54% for the first quarter of 2011 and 2010, respectively.  This decline in reported gross margin was primarily attributable to 1) higher non cash depreciation expense in our cost of revenue in the first quarter of 2011 as compared to the first quarter of 2010 as the result of a larger amount of hardware purchased by the Company to support new hospital implementations, and 2) a larger than normal level of lower margin hardware purchases by certain hospital customers during the first quarter of 2011 who implemented our solution during the quarter.  The gross margins realized from the sale of recurring disposable products (i.e. sponges and towels that make up the vast majority of our revenue), were 55% and 56% during the first quarters of 2011 and 2010, respectively.

As a result of a comprehensive restructuring program focused on a number of initiatives including reducing cash operating expenses, our operating expenses in the first quarter of 2011 were reduced significantly as compared to the first quarter of 2010.  Reported operating expenses were $1.8 million and $2.7 million for the first quarters of 2011 and 2010, respectively, a decrease of $0.9 million or 34%.  Excluding the effects of non-cash and certain one-time expenses, operating expenses were $1.4 million and $2.2 million, a decrease of $0.8 million or 36%.  The Company generated an Adjusted Operating Loss (defined as reported operating income ad
'/>"/>

SOURCE Patient Safety Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
3. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
7. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
8. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
9. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
10. Many Heart Attack Patients Dont Get Best Emergency Treatment
11. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... 2015 PharmaPoint: Type 1 Diabetes - Global Drug ... 1 diabetes (T1D) is an autoimmune disease that permanently destroys ... body can no longer produce insulin. Over the last 90 ... no other treatment can be offered to a patient who ... with different times of action - long-acting as well as ...
(Date:5/27/2015)... , May 27, 2015 The prevalence of ... by accelerated aging of population and changes in consumption ... has been growing year after year, thereby promoting the ... cases in China totaled 454,505 ... the interventional cardiovascular device industry there was worth RMB20.12 ...
(Date:5/27/2015)... 27, 2015 Research ... addition of the  "Asia Pacific Ultrasound Devices ... - 2019)"  company profile to their ... , ,Ultrasound is a type of imaging. ... at body parts and structures inside the ...
Breaking Medicine Technology:PharmaPoint: Type 1 Diabetes - Global Drug Forecast and Market Analysis to 2023 2PharmaPoint: Type 1 Diabetes - Global Drug Forecast and Market Analysis to 2023 3PharmaPoint: Type 1 Diabetes - Global Drug Forecast and Market Analysis to 2023 4China Interventional Cardiovascular Device Industry Report, 2014-2017 2China Interventional Cardiovascular Device Industry Report, 2014-2017 3Asia Pacific Ultrasound Devices Market Report 2015 - Growth, Trends And Forecasts 2014 - 2019 2
... Astellas Pharma US, Inc. ("Astellas") recently hired Mark ... oncology. Reporting directly to Patrick Shea, senior vice ... responsible for all U.S. commercial activities supporting marketed ... lead commercial planning for early stage development compounds. ...
... The Targetech Innovation Center, supported by a strategic ... developing pipeline of biomedical device opportunities poised to begin ... "This is an exciting development in the strategic ... effort, we will see more companies locating to Akron. ...
Cached Medicine Technology:Astellas Announces Vice President of Sales and Marketing for U.S. Oncology Franchise 2Akron Relationship with Israeli Incubator, Targetech, Shows Promise 2Akron Relationship with Israeli Incubator, Targetech, Shows Promise 3
(Date:5/27/2015)... (PRWEB) May 27, 2015 “ Nursing Homes ... care ,” reads the title of a recent April 2015 ... take elderly loved ones to the hospital, 20-plus years of ... This research shows that high-quality nursing homes are both safer ... With the quality of nursing homes varying widely, patients and ...
(Date:5/27/2015)... While hair transplantation has been used successfully ... study conducted by a physician member of the International ... follicle grafting can help treat patients with non-healing chronic ... ISHRS, which offers research grants for the purpose of ... In the past decade, numerous scientific studies have corroborated ...
(Date:5/27/2015)... The new http://www.carsonenergy.com includes ... should consider oil and gas investing, the substantial tax ... drilled, industry news, IRA investing, definitions and acronyms, info-graphics ... knowledge and experience is now in one central location, ... able to access 24 hours a day, 7 days ...
(Date:5/27/2015)... (PRWEB) May 27, 2015 CURE® ... (BCAN) , whose mission is to advance research, provide ... have joined forces to battle the fifth most common ... the bladder’s lining start to grow out of control. ... their families at every stage of the cancer experience ...
(Date:5/27/2015)... Difass USA, a modern supplement brand committed ... first three flagship products, Dormiva™, Relaxiva™ and Reminiva™. All ... http://www.difassusa.com . , A restful night’s sleep is ... people struggle with getting the full amount of sleep ... designed to help you fall asleep and stay asleep, ...
Breaking Medicine News(10 mins):Health News:BestNursingHomes.com Launches on National Senior Health and Fitness Day 2Health News:New Research Finds Hair Grafting a Promising Therapy for Chronic Leg Ulcers - International Society of Hair Restoration Surgery Awards Research Grant 2Health News:New Research Finds Hair Grafting a Promising Therapy for Chronic Leg Ulcers - International Society of Hair Restoration Surgery Awards Research Grant 3Health News:Carson Energy Launches Next Generation Investor Website 2Health News:CURE® Magazine and Bladder Cancer Advocacy Network Align to Increase Awareness of Fifth Most Common Type of Cancer 2Health News:CURE® Magazine and Bladder Cancer Advocacy Network Align to Increase Awareness of Fifth Most Common Type of Cancer 3Health News:Supplement Brand Difass USA Launches in the U.S. with Three Flagship Products Designed to Bring Balance Back to Your Life 2
... Star Health is out with a gift ... and Allied Company Ltd . has extended a proposal ... to provide insurance coverage for those with the HIV ... affected persons across India. ,According to Jagannathan, Chairman ...
... new study,the rogue proteins that cause chronic wasting disease ... when bound to common soil particles . ... Pathogens, a group led by University of Wisconsin-Madison prion ... of a family of fatal brain disorders, bind tightly ...
... sister, five of her aunts, one great, great aunt and six ... just found out that "the beast" has attacked her too. ... M25 waiting for a lorry to hit me," says Shirley McQueen, ... ,"The beast" is a particularly virulent form of breast ...
... The psychology researchers have published their findings in Are Women ... Science . , ,Refuting the popular stereotype that females ... at Austin have found women and men both use an ... a decade, researchers have claimed that women use far more ...
... reported progress in understanding the mechanism underlying that death, ... ,In the vast majority of Parkinsons disease ... genetic defect, but because some external insult triggers the ... and human patients, the researchers have found evidence that ...
... sales of a leukemia and arthritis drug due to ... the latest incident to plague the nation's medicine industry. ... have been called into serious question both domestically and ... tainted food. ,The State Food and Drug ...
Cached Medicine News:Health News:Star Health Grants Boon To India's HIV-Affected 2Health News:Prions Capacity can Be Aggrevated by Solid Particles 2Health News:Prions Capacity can Be Aggrevated by Solid Particles 3Health News:British Woman Who Has inherited Breast Cancer Wants to Spread Awareness 2Health News:British Woman Who Has inherited Breast Cancer Wants to Spread Awareness 3Health News:British Woman Who Has inherited Breast Cancer Wants to Spread Awareness 4Health News:Parkinsons Disease Mechanism Identified 2
... macular health. Snellen charts available ... Easy to mount on most ... in a few minutes. Rapid ... Retinal vision testing without refraction ...
Eye Q Lite is ideal for color and red-free imaging used in general clinical and optometric casework such as anterior segmenting and diabetic screening....
The Genesis Camera meets the needs of those with specific requirements that cannot be met by a conventional 'chinrest' type camera....
The quick access to diabetic screening, panoramic images of the retina including peripheral area are available by using easy, semi automatic guidance of peripheral fixation....
Medicine Products: